Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 4, 2003, Pages 222-226

  Kato, N ^a   Watanabe, J ^b   Jobo, T ^b   Nishimura, Y ^a   Fujisawa, T ^a   Kamata, Y ^a   Kuramoto, H ^a  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinogenesis; Clinicopathological parameters; Cyclin E; Endometrial adenocarcinoma

Indexed keywords

BIOTIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN; STREPTAVIDIN;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0038792572     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0426-x     Document Type: Article

References (38)

1. KIP1 in uterine endometrial carcinoma: relationship with p53 status. Int J Surg Pathol 6:205-212
2. Akaboshi M, Watanabe J, Fujisawa T, Hattori M, Ohno E, Kuramoto H (2001) Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma. J Jpn Soc Clin Cytol 40:121-127 (in Japanese)
3. KIP1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 79:439-443
4. Dellas A, Schultheiss E, Leivas MR, Moch H, Torhorst J (1998) Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 18:3991-3996
5. Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 155:1129-1136
6. Dobashi Y, Shoji M, Jiang SX, Kobayashi M, Kawakubo Y, Kameya T (1998) Active cyclin A-cdk2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 153:963-972
7. Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y (2001) A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Cancer Res 61:2500-2504
8. Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92:770-777
9. FIGO news (1989) Int J Gynecol Obstet 28:189-193
10. Fujisawa T, Watanabe J, Akaboshi M, Ohno E, Kuramoto H (2001) Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 127:668-674
11. Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol 187:200-206
12. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC (1996) Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 62:192-198
13. Ito K, Sasano H, Yoshida Y, Sato S, Yajima A (1998) Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Res 18:1661-1664
14. Jobo T, Tateoka K, Kuramoto H (1996) Study on the long-term follow-up of endometrial hyperplasia. Int J Clin Oncol 1:163-169
15. Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol 153:505-513
16. Keyomarsi K, Herliczek TW (1997) The role of cyclin E in cell proliferation, development and cancer. Prog Cell Cycle Res 3:171-191
17. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385
18. Li JQ, Miki H, Ohmori M, Wu F, Funamoto Y (2001) Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum Pathol 32:945-953
19. Makiyama K, Masuda M, Takano Y, Iki M, Asakura T, Suwa Y, Noguchi S, Hosaka M (2000) Cyclin E overexpression in transitional cell carcinoma of the bladder. Cancer Lett 151:193-198
20. Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S, Scambia G, Giordano A (1999) Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res 59:3790-3794
21. Milde-Langosch K, Bamberger AM, Goemann C, Rossing E, Rieck G, Kelp B, Loning T (2001) Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 127:537-544
22. Nielsen NH, Arnerlov C, Emdin SO, Landberg G (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74:874-880
23. Nycum LR, Smith LM, Farley JH, Kost ER, Method MW, Birrer MJ (2001) The role of p27 in endometrial carcinoma. Gynecol Oncol 81:242-246
24. Ohkawara S, Jobo T, Sato R, Kuramoto H (2000) Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia. Eur J Gynaecol Oncol 21:573-577
25. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225
26. Resnitzky D, Gossen M, Bujard H, Reed SI (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679
27. Russo AA, Jeffery PD, Patten AK, Massague J, Pavletich NP (1996) Crystal structures of the p27kip cyclin-dependent kinase inhibitor bound to the cyclin A-cdk complex. Nature 382:325-331
28. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T, Nakano H (1998) Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82:1238-1243
29. Sauer K, Lehner CF (1995) The role of cyclin E in the regulation of entry into the S phase. Prog Cell Cycle Res 1:125-139
30. Sawasaki T, Shigemasa K, Shiroyama Y, Kusuda T, Fujii T, Parmley TH, O'Brien TJ, Ohama K (2001) Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation. J Soc Gynecol Invest 8:179-185
31. Scott KA, Walker RA (1997) Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 76:1288-1292
32. KIP1 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 58:152-158
33. Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S (1999) Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 85:669-677
34. Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ, Iacopetta BJ (1996) Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 74:562-567
35. kip1 and cyclin D1 in epithelial ovarian tumors. Gynecol Oncol 73:202-209
36. Watanabe J, Sato H, Kanai T, Kamata Y, Jobo T, Hata H, Fujisawa T, Ohno E and Kuramoto H (2002) Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters. Br J Cancer 87:81-85
37. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R (1994) Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9:995-997
38. Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E (1996) Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch 429:13-19